Top Industry Leaders in the Biomarker Technologies Market
Latest Biomarker Technologies Companies Updates:
Roche Diagnostics Introduced the Elecsys® Alphascreen™ platform, offering highly sensitive immunoassays for detecting low-abundance protein biomarkers, opening doors for early diagnosis and improved disease monitoring.
Agilent Technologies Launched the Crissy™ CR System, a compact and affordable mass spectrometry system for biomarker analysis, aiming to make this technology more accessible for smaller laboratories and clinical settings.
Illumina: Developed the NovaSeq™ 6000 Sequencing System, featuring faster sequencing speeds and higher throughput, enabling efficient analysis of large-scale biomarker studies.Thermo Fisher Scientific: Acquired Personalis, Inc., a leader in next-generation sequencing (NGS) and clinical genomics, strengthening its presence in personalized medicine and expanding its portfolio of biomarker testing solutions.
Danaher Corporation Partnered with University of California, San Diego to develop novel AI-powered algorithms for analyzing mass spectrometry data from metabolic biomarker testing, aiming to improve diagnostic accuracy and personalized treatment recommendations.
Pfizer Inc. Collaborated with academic institutions and research centers to explore the potential of AI-powered biomarker analysis for personalized drug development and targeted therapies.
List of Biomarker Technologies Key companies in the market:
- Abbott Laboratories
- Agilent Technologies
- Thermo Fisher Scientific
- Roche
- Waters Corporation
- Danaher Corporation
- Shimadzu Corporation
- Danaher Corporation
- Siemens Healthcare